BDTX
Black Diamond Therapeutics Inc

2,704
Mkt Cap
$152.12M
Volume
2.11M
52W High
$4.94
52W Low
$1.20
PE Ratio
7.36
BDTX Fundamentals
Price
$2.67
Prev Close
$2.71
Open
$2.87
50D MA
$3.86
Beta
1.76
Avg. Volume
1.18M
EPS (Annual)
-$1.27
P/B
1.21
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Lowered by Guggenheim
Guggenheim downgraded Black Diamond Therapeutics from a "buy" rating to a "neutral" rating in a research report on Wednesday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)
Black Diamond (BDTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·2d ago
News Placeholder
Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)
Black Diamond (BDTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·2d ago
News Placeholder
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
Zacks·8d ago
News Placeholder
Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)
Piper Sandler began coverage on shares of Black Diamond Therapeutics in a research note on Tuesday. They set an "overweight" rating and a $9.00 price objective on the stock...
MarketBeat·17d ago
News Placeholder
What is HC Wainwright's Forecast for BDTX FY2025 Earnings?
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - Research analysts at HC Wainwright boosted their FY2025 EPS estimates for Black Diamond Therapeutics in a note issued to investors on...
MarketBeat·21d ago
News Placeholder
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
Zacks·24d ago
News Placeholder
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?
Black Diamond (BDTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·24d ago
News Placeholder
Black Diamond Therapeutics (NASDAQ:BDTX) Releases Earnings Results
Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.22...
MarketBeat·29d ago
News Placeholder
Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?
Black Diamond Therapeutics gears up for Q3 results as investors eye key silevertinib data and additional development plans.
Zacks·1mo ago

Latest BDTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.